Tech Company Financing Transactions

Pheast Therapeutics Funding Round

On 4/26/2022, Pheast Therapeutics raised $76 million in Series A funding from Arch Venture Partners, Catalio Capital Management and Alexandria Venture Investments.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Palo Alto, CA Undisclosed
United States

Phone

Undisclosed

Website

www.pheast.com

Email Address

Not Recorded

Overview

Pheast Therapeutics is a cancer immunotherapy company focused on developing novel checkpoint therapies to harness the innate immune system in the fight against cancer

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

        

Browse more venture capital transactions:

Prev: 4/26/2022: Qualified.com venture capital transaction
Next: 4/26/2022: Adept AI Labs venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document tech company VC transactions. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary